Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes.

Slides:



Advertisements
Similar presentations
Hematology The Study of Blood Blood contains cells, proteins, and sugars Red blood cells transport oxygen- erythrocytes White blood cells are part of the.
Advertisements

Red blood cells mediate the onset of thrombosis in the ferric chloride murine model by Justin D. Barr, Anil K. Chauhan, Gilbert V. Schaeffer, Jessica K.
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.
Robert G. Presson, Mary Beth Brown, Amanda J. Fisher, Ruben M
Date of download: 12/22/2017 Copyright © ASME. All rights reserved.
Biomechanics and biorheology of red blood cells in sickle cell anemia
AF647-RIS is internalized by TAMs in vivo.
Do HSCs divide asymmetrically?
TCR-MHC-peptide(s): in vivo veritas
Inhibition of cell adhesion by anti–P-selectin aptamer: a new potential therapeutic agent for sickle cell disease by Diana R. Gutsaeva, James B. Parkerson,
Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B by Richard H. Sohn, Clayton.
Recombinant PfEMP1 peptide inhibits and reverses cytoadherence of clinical Plasmodium falciparum isolates in vivo by Bryan G. Yipp, Dror I. Baruch, Ciaran.
by Qin Wang, Eddie T. Chiang, Mark Lim, Jean Lai, Rick Rogers, Paul A
Finding a diamond in the (mouse is) rough
by Dachuan Zhang, Chunliang Xu, Deepa Manwani, and Paul S. Frenette
by Cornelia Halin, Nadja E. Tobler, Benjamin Vigl, Lawrence F
Mechanical Properties of Stored Red Blood Cells Using Optical Tweezers
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy by Emanuela Zappia, Simona Casazza, Enrico Pedemonte,
Clinical response to F16-IL2 and LDAC in patients with AML bone marrow involvement. Clinical response to F16-IL2 and LDAC in patients with AML bone marrow.
Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea by Camila Bononi Almeida, Lucas.
Antibody–mediated C5 inhibition in hepatocyte-Cfh−/− mice during accelerated serum NTN. (A) Hematuria, (B) serum urea, (C) red cell fragments, (D) glomerular.
Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis by Lisa A. Michaels, Kwaku.
Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito by Shigeto Yoshida,
by Rong Deng, and Joseph P. Balthasar
Hemoglobin levels in African-Americans
A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor.
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase by Frank A. D. T. G. Wagener, Andreas Eggert, Otto C. Boerman, Wim.
by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T
Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1)‏ by Kaisa Koskinen, Petri.
by Natalie J. Foot, Yew Ann Leong, Loretta E. Dorstyn, Hazel E
Differential Effect of E-Selectin Antibodies on Neutrophil Rolling and Recruitment to Inflammatory Sites by Carroll L. Ramos, Eric J. Kunkel, Michael B.
by Éric Aubin, Réal Lemieux, and Renée Bazin
by Lori A. Styles, Anton J. Aarsman, Elliott P. Vichinsky, and Frans A
VCAM-1 is more effective than MAdCAM-1 in supporting eosinophil rolling under conditions of shear flow by P. Sriramarao, Richard G. DiScipio, Ronald R.
Platelets can enhance vascular permeability
C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen by Gerald.
HU for acute treatment of sickle VOC?
The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via β2 integrins (CD11/CD18)‏ by Ludwig T. Weckbach,
by Kelly A. McGowan, Wendy W. Pang, Rashmi Bhardwaj, Marcelina G
Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion by John D. Belcher, Paul H. Marker,
by Michael Bezuhly, Robyn Cullen, Charles T. Esmon, Steven F
Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice by Kellie R. Machlus, Jessica C. Cardenas, Frank C.
Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease by Stéphane M. Camus, Blandine Gausserès, Philippe.
Fig. 5 Combination intravenous reovirus and checkpoint inhibition in an orthotopic syngeneic brain tumor model. Combination intravenous reovirus and checkpoint.
Robust adaptive immune response against Babesia microti infection marked by low parasitemia in a murine model of sickle cell disease by Woelsung Yi, Weili.
Advances in the Treatment of Sickle Cell Disease
TNF-α–stimulated adhesion of HL60 cells to HCMEC is inhibited by neuraminidase but not by NaClO3 . TNF-α–stimulated adhesion of HL60 cells to HCMEC is.
by Hendra Setiadi, Tadayuki Yago, Zhenghui Liu, and Rodger P. McEver
Volume 2(Supplement 1):1-3
Characterization of the activity of RBCs bound by hTM-scFv fusions and their therapeutic efficacy in a microfluidic model of inflammatory thrombosis. Characterization.
by Tadayuki Yago, Nan Zhang, Liang Zhao, Charles S
by Nicholas J. Laping, Michael P. DeMartino, Joshua E
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
Salvador González, Robert Sackstein, R
Volume 85, Issue 1, Pages (January 2014)
Schematic depiction of CTC processing methods.
Volume 57, Issue 6, Pages (June 2000)
PD-L1 selectively marks circulating NCMs.
Interactions of neutrophil-derived OSM with gp130-containing receptors on endothelial cells enhance P-selectin–dependent rolling in mouse postcapillary.
Chop deletion preserves β-cell function in P58IPK−/− mice.
Diclofenac treatment reduces L-selectin on peripheral blood and infiltrated leukocytes but does not alter accumulation in the injured spinal cord. Diclofenac.
PTZ-induced neuronal activity visualized by IEGs
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor.
In vivo assessment of synergistic activity of MV-CEA and RT in a U87 s
Central nervous system–restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation by Hojun Li, Leslie A. Benson,
Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent regulation of tumor growth. Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent.
TCR stimulation by agonistic mAb in vivo administration inhibits mouse T-ALL development. TCR stimulation by agonistic mAb in vivo administration inhibits.
MGA271 exhibits potent in vivo antitumor activity toward tumor cell carcinoma xenografts. MGA271 exhibits potent in vivo antitumor activity toward tumor.
A, Natalizumab blocks the adhesion of leukocytes to endothelial cells by blocking the interaction of the α4-integrin subunit of α4β1 with VCAM-1 and of.
PDL192 and inhibit the growth of xenograft tumors.
Presentation transcript:

Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes by Aslihan Turhan, Pegah Jenab, Pierre Bruhns, Jeffrey V. Ravetch, Barry S. Coller, and Paul S. Frenette Blood Volume 103(6):2397-2400 March 15, 2004 ©2004 by American Society of Hematology

IVIG prevents both the interactions between sickle RBCs and WBCs and vaso-occlusion in sickle cell mice. IVIG prevents both the interactions between sickle RBCs and WBCs and vaso-occlusion in sickle cell mice. (A) IVIG reduces RBC-WBC interactions in vivo in a dose-dependent manner; differences were significant for the groups treated with IVIG at 200 mg/kg or more. #P ≤ .01 compared with PBS, P < .05 compared with the albumin-treated group. (B) IVIG 400 mg/kg improves centerline RBC velocities (VRBC) in venules as measured during IVM 1 in real time using an optical Doppler velocimeter (Texas A&M, College Station), and the effect is sustained after TNF-α (IVM 2). *P < .05 compared with the albumin group. #P< .05 compared with both the PBS and albumin groups. ¶Groups in which the numbers of live mice and venules were too small for reliable determination. (C) Representative still frames after TNF-α administration of venules from sickle cell mice treated with 1 mg/kg or 400 mg/kg IVIG. In venules of sickle mice treated with low-dose IVIG, there are numerous interactions between RBCs (black arrows) and adherent WBCs (white arrows) accompanied by drastic reductions in blood flow in most venules. Fewer RBC-WBC interactions and adherent WBCs are observed in sickle mice treated with high-dose IVIG. Scale bar indicates 10 μm. Movie segments corresponding to these still frames (C-D) can be viewed on the Blood website. See the Supplemental Video link at the top of the online article. Aslihan Turhan et al. Blood 2004;103:2397-2400 ©2004 by American Society of Hematology